Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Epimax Paraffin-Free cream
21220000306
|
Epimax Paraffin-Free cream | Emollients | Appliances | No data available |
|
Epimaz 100mg tablets
0408010C0BCAAAB
|
Epimaz | Carbamazepine | Central Nervous System | No data available |
|
Epimaz 200mg tablets
0408010C0BCABAC
|
Epimaz | Carbamazepine | Central Nervous System | No data available |
|
Epimaz 400mg tablets
0408010C0BCACAD
|
Epimaz | Carbamazepine | Central Nervous System | No data available |
|
Epimaz Retard 200mg tablets
0408010C0BCADAG
|
Epimaz | Carbamazepine | Central Nervous System | No data available |
|
Epimaz Retard 400mg tablets
0408010C0BCAEAH
|
Epimaz | Carbamazepine | Central Nervous System | No data available |
|
Epirubicin 100mg/50ml solution for infusion vials
0801020N0AAAGAG
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 10mg powder for solution for injection vials
0801020N0AAAAAA
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 10mg/5ml solution for injection vials
0801020N0AAADAD
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 200mg/100ml solution for infusion vials
0801020N0AAAFAF
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 20mg powder for solution for injection vials
0801020N0AAABAB
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 20mg/10ml solution for injection vials
0801020N0AAAIAI
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 50mg powder for solution for injection vials
0801020N0AAACAC
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 50mg/25ml solution for injection vials
0801020N0AAAEAE
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Episenta 1g/10ml solution for injection ampoules
0408010W0BIAFBU
|
Episenta | Sodium valproate | Central Nervous System | No data available |
|
Episil Absorbent dressing 15cm x 20cm
20030900095
|
Episil Absorbent dressing 15cm x 20cm | Wound Management & Other Dressings | Dressings | No data available |
|
Epivir 150mg tablets
0503010Q0BBAAAA
|
Epivir | Lamivudine | Infections | No data available |
|
Epivir 300mg tablets
0503010Q0BBACAE
|
Epivir | Lamivudine | Infections | No data available |
|
Epivir 50mg/5ml oral solution
0503010Q0BBABAB
|
Epivir | Lamivudine | Infections | No data available |
|
Epoetin alfa 2,000units/1ml inj pre-filled syringes
0901030D0AAAWAW
|
Epoetin alfa | Epoetin alfa | Nutrition and Blood | No data available |
|
Epoetin alfa 40,000units/1ml solution for injection vials
0901030D0AAASAS
|
Epoetin alfa | Epoetin alfa | Nutrition and Blood | No data available |
|
Epoetin alfa 7,000units/0.7ml inj pre-filled syringes
0901030D0AAAPAP
|
Epoetin alfa | Epoetin alfa | Nutrition and Blood | No data available |
|
Epoetin alfa 9,000units/0.9ml inj pre-filled syringes
0901030D0AAARAR
|
Epoetin alfa | Epoetin alfa | Nutrition and Blood | No data available |
|
Epoetin beta 1,000units/0.3ml inj pre-filled syringes
0901030E0AAAPAP
|
Epoetin beta | Epoetin beta | Nutrition and Blood | No data available |
|
Epoetin beta 10,000unit inj pre-filled disposable devices
0901030E0AAAIAI
|
Epoetin beta | Epoetin beta | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.